A decision by the U.S. Court of Appeals for the Federal Circuit sets forth a “bright line rule” concerning patent eligibility and is “significant” to a dietary supplement industry invested in research and innovation, according to a lawyer who...
Attorney Ronald J. Levine addresses a hypothetical sauce company’s recall management by imagining a fictional discussion with its CEO. The sauce company may be made-up, but the issues are quite real.
Government officials alleged three companies made claims about their CBD products’ ability to treat cancer and other serious diseases without adequate evidence.
Class action lawsuits claiming supplement nutrient-content claims are on the rise, so brands must be vigilant in ensuring all claims meet requirements outlined in FDA’s Federal Food, Drug and Cosmetic Act (FD&C).
FTC announced its case against New York-based Cure Encapsulations Inc. and its owner, Naftula Jacobowitz, was the first one “challenging a marketer’s use of fake paid reviews on an independent retail website.”
Jonathan Doyle of Dallas-based USPlabs LLC, a distributor of dietary supplements, agreed he committed “all the essential elements” of a criminal count in a superseding indictment. The development comes just weeks before a scheduled jury trial in a...
A controversy before the U.S. Court of Appeals for the Ninth Circuit raises questions as to how judges should apply a fundamental legal principle—"summary judgment”—in false advertising cases.
In this Q&A with four health and nutrition industry attorneys, INSIDER explored two court decisions with potentially broad implications, FTC's priorities under a Republican administration and the agency's guidelines pertaining to social media.
